Literature DB >> 21289825

The management of neuroleptic-induced CNS effects.

B F Hoffman, M V Seeman.   

Abstract

Basal ganglia side effects caused by the neuroleptic drugs include the acute extrapyramidal syndromes (dystonias, akathisia and parkinsonism) and tardive dyskinesia. These may be ignored, misdiagnosed or mistreated by the patient or physician. Because the neuroleptics are effective in the treatment and secondary prevention of serious psychiatric disorders such as schizophrenia, it is important that neurological side effects be anticipated and appropriately managed. This increases patient compliance and enhances the therapeutic relationship. Patients should be examined frequently and systematically for basal ganglia side effects. (Can Fam Physician 1981; 27:1615-1624).

Entities:  

Year:  1981        PMID: 21289825      PMCID: PMC2306233     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  31 in total

1.  ANTI-PARKINSONISM DRUG THERAPY.

Authors:  D G FRIEND
Journal:  Clin Pharmacol Ther       Date:  1963 Nov-Dec       Impact factor: 6.875

2.  Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia.

Authors:  D Gagrat; J Hamilton; R H Belmaker
Journal:  Am J Psychiatry       Date:  1978-10       Impact factor: 18.112

3.  Toxic effects of amantadine in patients with renal failure.

Authors:  T S Ing; J T Daugirdas; L S Soung; H L Klawans; S D Mahurkar; J A Hayashi; W P Geis; J E Hano
Journal:  Can Med Assoc J       Date:  1979-03-17       Impact factor: 8.262

4.  Benztropine psychosis.

Authors:  J V Ananth; R C Jain
Journal:  Can Psychiatr Assoc J       Date:  1973-10

5.  The therapeutic use of diazepam for akathisia.

Authors:  P T Donlon
Journal:  Psychosomatics       Date:  1973 Jul-Aug       Impact factor: 2.386

6.  Abnormal involuntary movements induced by anticholinergic therapy.

Authors:  E Birket-Smith
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

7.  Diazepam in the treatment of tardive dyskinesia. Preliminary observations.

Authors:  M M Singh
Journal:  Int Pharmacopsychiatry       Date:  1976

8.  Open withdrawal of antiparkinson drugs in the neuroleptic- induced Parkinson syndrome.

Authors:  J Fleischhauer
Journal:  Int Pharmacopsychiatry       Date:  1975

9.  Changes in prevalence, severity, and recovery in tardive dyskinesia with age.

Authors:  J M Smith; R J Baldessarini
Journal:  Arch Gen Psychiatry       Date:  1980-12

10.  Tardive dyskinesia: clinical, biological, and pharmacological perspectives.

Authors:  P A Berger; K Rexroth
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.